A randomised trial of intravenous or nebulised magnesium sulphate versus placebo for acute severe asthma.

Aim

To assess the effectiveness of IV and nebulised magnesium sulphate in the treatment of acute severe asthma.

Trial Design

Multi centre randomised controlled trial of intravenous (IV) or nebulised magnesium sulphate versus placebo for acute severe asthma

Chief Investigator

Professor Steve Goodacre

Local PI

Professor Alasdair Gray

List of Publications – references

S Goodacre, J Cohen, M Bradburn, A Gray, J Benger, T Coats on behalf of the 3Mg Research Team. The 3Mg Trial: Randomised controlled trial of intravenous or nebulised magnesium sulphate or standard therapy for severe acute asthma. The Lancet Respiratory Medicine. (2013); 1:293 – 300.

Goodacre S, Cohen J, Bradburn M, Stevens J, Gray A, Benger J, et al. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma. . Health Technology Assessment. (2014);18(22).